Detalles de la búsqueda
1.
Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
Pediatr Blood Cancer
; 66(8): e27785, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31044544
2.
Recently Evolved Enhancers Emerge with High Interindividual Variability and Less Frequently Associate with Disease.
Cell Rep
; 31(12): 107799, 2020 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-32579926
3.
Hominin-specific regulatory elements selectively emerged in oligodendrocytes and are disrupted in autism patients.
Nat Commun
; 11(1): 301, 2020 01 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-31949148
4.
AML Subtype Is a Major Determinant of the Association between Prognostic Gene Expression Signatures and Their Clinical Significance.
Cell Rep
; 28(11): 2866-2877.e5, 2019 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31509748
5.
Transcriptomic and Epigenomic Profiling of Histone Deacetylase Inhibitor Treatment Reveals Distinct Gene Regulation Profiles Leading to Impaired Neutrophil Development.
Hemasphere
; 3(4): e270, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31723844
Resultados
1 -
5
de 5
1
Próxima >
>>